Monitoring intracellular melatonin levels in human prostate normal and cancer cells by HPLC

Analytical and Bioanalytical Chemistry

Volumn 397, Issue 3, 2010, Pages 1235-1244

  Hevia, D ^a,b   Mayo, J C ^a   Quiros, I ^a   Gomez Cordoves, C ^b   Sainz, R M ^a  

^a DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^b INSTITUTO DE FERMENTACIONES INDUSTRIALES CSIC   (Spain)

Author keywords

Cancer; HPLC; Melatonin; Prostate cells

Indexed keywords

CELL CULTURE; DISEASES; FREE RADICALS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORMONES; LIQUIDS; PHYSIOLOGY; POLYCYCLIC AROMATIC HYDROCARBONS; TUMORS; UROLOGY;

ANTI-PROLIFERATIVE ACTIVITIES; ANTIPROLIFERATIVE PROPERTIES; CANCER; DETECTION AND QUANTIFICATIONS; HPLC; MELATONIN; PROSTATE CELLS; RELATIVE STANDARD DEVIATIONS;

CELLS;

EID: 77953479541     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-010-3653-4     Document Type: Article

References (36)

1. Lerner AB, Case JD, Takahashi Y, Lee TH, Mori W (1958) Isolation of melatonin, pineal factor that lightens melanocytes. J Am Chem Soc 80:2587
2. Reiter RJ (1991) Melatonin: the chemical expression of darkness. Mol Cell Endocrinol 79:C153-C158
3. Kvetnoy IM (1999) Extrapineal melatonin: location and role within diffuse neuroendocrine system. Histochem J 31:1-12
4. Hardeland R, Poeggeler B (2003) Non-vertebrate melatonin. J Pineal Res 34:233-241
5. Marczynski TJ, Yamaguchi N, Ling GM, Grodzinska L (1964) Sleep induced by the administration of melatonin (5-methoxyn-acetyltryptamine) to the hypothalamus in unrestrained cats. Experientia 20:435-437
6. Reiter RJ (1980) The pineal and its hormones in the control of reproduction in mammals. Endocr Rev 1:109-131
7. Reiter RJ, Tan DX, Manchester LC, El-Sawi MR (2002) Melatonin reduces oxidant damage and promotes mitochondrial respiration: implications for aging. Ann NY Acad Sci 959:238-250
8. Pappolla MA, Sos M, Omar RA, Bick RJ, Hickson-Bick DL, Reiter RJ, Efthimiopoulos S, Robakis NK (1997) Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide. J Neurosci 17:1683-1690
9. Luchetti F, Canonico B, Curci R, Battistelli M, Mannello F, Papa S, Tarzia G, Falcieri E (2006) Melatonin prevents apoptosis induced by UV-B treatment in U937 cell line. J Pineal Res 40:158-167
10. Matsubara E, Bryant-Thomas T, Pacheco QJ, Henry TL, Poeggeler B, Herbert D, Cruz-Sanchez F, Chyan YJ, Smith MA, Perry G, Shoji M, Abe K, Leone A, Grundke-Ikbal I, Wilson GL, Ghiso J, Williams C, Refolo LM, Pappolla MA, Chain DG, Neria E (2003) Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease. J Neurochem 85:1101-1108
11. Quiros I, Sainz RM, Hevia D, Garcia-Suarez O, Astudillo A, Rivas M, Mayo JC (2009) Upregulation of manganese superoxide dismutase (SOD2) is a common pathway for neuroendocrine differentiation in prostate cancer cells. Int J Cancer 125:1497-1504
12. Cardinali DP, Esquifino AI, Srinivasan V, Pandi-Perumal SR (2008) Melatonin and the immune system in aging. Neuroimmunomodulation 15:272-278
13. Mayo JC, Sainz RM, Uria H, Antolin I, Esteban MM, Rodriguez C (1998) Melatonin prevents apoptosis induced by 6-hydroxydopamine in neuronal cells: implications for Parkinson's disease. J Pineal Res 24:179-192
14. Jin BK, Shin DY, Jeong MY, Gwag MR, Baik HW, Yoon KS, Cho YH, Joo WS, Kim YS, Baik HH (1998) Melatonin protects nigral dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP +) neurotoxicity in rats. Neurosci Lett 245:61-64
15. Bartsch C, Bartsch H, Jain AK, Laumas KR, Wetterberg L (1981) Urinary melatonin levels in human breast cancer patients. J Neural Transm 52:281-294
16. Bartsch C, Bartsch H, Fluchter SH, Attanasio A, Gupta D (1985) Evidence for modulation of melatonin secretion in men with benign and malignant tumors of the prostate: relationship with the pituitary hormones. J Pineal Res 2:121-132
17. El-Domeiri AA, Das Gupta TK (1973) Reversal by melatonin of the effect of pinealectomy on tumor growth. Cancer Res 33:2830-2833
18. Bejarano I, Redondo PC, Espino J, Rosado JA, Paredes SD, Barriga C, Reiter RJ, Pariente JA, Rodriguez AB (2009) Melatonin induces mitochondrial-mediated apoptosis in human myeloid HL-60 cells. J Pineal Res 46:392-400
19. Sainz RM, Mayo JC, Tan DX, Lopez-Burillo S, Natarajan M, Reiter RJ (2003) Antioxidant activity of melatonin in Chinese hamster ovarian cells: changes in cellular proliferation and differentiation. Biochem Biophys Res Commun 302:625-634
20. Sainz RM, Mayo JC, Tan DX, Leon J, Manchester L, Reiter RJ (2005) Melatonin reduces prostate cancer cell growth leading to neuroendocrine differentiation via a receptor and PKA independent mechanism. Prostate 63:29-43
21. Ralph CL, Lynch HJ (1970) A quantitative melatonin bioassay. Gen Comp Endocrinol 15:334-338
22. Wetterberg L, Eriksson O, Friberg Y, Vangbo B (1978) A simplified radioimmunoassay for melatonin and its application to biological fluids. Preliminary observations on the half-life of plasma melatonin in man. Clin Chim Acta 86:169-177
23. Miller FP, Maickel RP (1970) Fluorimetric determination of indole derivatives. Life Sci 9:747-752
24. Cattabeni F, Koslow SH, Costa E (1972) Gas chromatographicmass spectrometric assay of four indole alkylamines of rat pineal. Science 178:166-168
25. Wilson B W (1978) The application of mass spectrometry to the study of the pineal gland. J Neural Transm. Suppl 279-288
26. Silva SO, Rodrigues MR, Ximenes VF, Bueno-da-Silva AE, Amarante-Mendes GP, Campa A (2004) Neutrophils as a specific target for melatonin and kynuramines: effects on cytokine release. J Neuroimmunol 156:146-152
27. Kulczykowska E, Iuvone PM (1998) Highly sensitive and specific assay of plasma melatonin using high-performance liquid chromatography with fluorescence detection preceded by solid-phase extraction. J Chromatogr Sci 36:175-178
28. Mills MH, Finlay DC, Haddad PR (1991) Determination of melatonin and monoamines in rat pineal using reversed-phase ion-interaction chromatography with fluorescence detection. J Chromatogr 564:93-102
29. Hamase K, Hirano J, Kosai Y, Tomita T, Zaitsu K (2004) A sensitive internal standard method for the determination of melatonin in mammals using precolumn oxidation reversed-phase high-performance liquid chromatography. J Chromatogr B 811:237-241
30. Vieira R, Miguez J, Lema M, Aldegunde M (1992) Pineal and plasma melatonin as determined by high-performance liquid chromatography with electrochemical detection. Anal Biochem 205:300-305
31. Raynaud F, Pevet P (1991) Determination of 5-methoxyindoles in pineal gland and plasma samples by high-performance liquid chromatography with electrochemical detection. J Chromatogr 564:103-113
32. Bromme HJ, Peschke E, Israel G (2008) Photo-degradation of melatonin: influence of argon, hydrogenperoxide, and ethanol. J Pineal Res 44:366-372
33. Hevia D, Sainz RM, Blanco D, Quiros I, Tan DX, Rodriguez C, Mayo JC (2008) Melatonin uptake in prostate cancer cells: intracellular transport versus simple passive diffusion. J Pineal Res
34. Ayano E, Suzuki Y, Kanezawa M, Sakamoto C, Morita-Murase Y, Nagata Y, Kanazawa H, Kikuchi A, Okano T (2007) Analysis of melatonin using a pH- and temperature-responsive aqueous chromatography system. J Chromatogr A 1156:213-219
35. Harumi T, Matsushima S (2000) Separation and assay methods for melatonin and its precursors. J Chromatogr B Biomed Sci Appl 747:95-110
36. US Department of Health and Human Services, Food and Drug Administration. Guidance for Industry, Bioanalytical Method Validation. http://www.fda.gov/ cder/guidance/index.htm. 2001